As of Apr 24
| -0.11 / -2.82%|
The 6 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 4.25, with a high estimate of 7.50 and a low estimate of 2.00. The median estimate represents a +12.14% increase from the last price of 3.79.
The current consensus among 6 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.